NanoEcho has today published the report for the third quarter! Watch as CEO Linda Persson summarises an eventful quarter, focusing on two key areas:
🏥 During the quarter, the operational team worked intensively to prepare for the dose confirmation study. Shortly after the end of the period, we were proud to announce that all preparations were complete, and recruitment of study participants has now begun.
🔔 In July, the new share issue was completed, raising approximately SEK 15 million. Following this, NanoEcho was listed on the Nasdaq First North Growth Market.